Left main and multivessel disease

Find all the latest content on left main and multivessel disease published on this website.

The left main coronary artery provides the primary source of blood flow to the left ventricle. Diseases affecting the left main, by itself or in combination with multivessel disease, place the patient at significant risk for life-threatening cardiovascular events. Treatment requires an understanding of all available tools, devices and techniques, like those employed in invasive imaging and functional assessment, as well as taking into account underlying comorbidities such as diabetes. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks. Use the filters below to access PCRonline resources.

Filtered By
Left main and multivessel disease

321 results

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with left main disease with and without diabetes: findings from a pooled analysis of 4 randomized clinical trials

30 Apr 2024

This analysis shows that diabetic patients undergoing revascularization face substantially higher 5-year rates of all-cause mortality, myocardial infarction, repeat revascularizations, and stroke compared to non-diabetic patients.

Alessandro Sticchi

Reviewer

Alessandro Sticchi
Prof. Antonio Colombo

Reviewer

Antonio Colombo
PCI vs CABG in patients with LM disease with and without diabetes: findings from a pooled analysis of 4 randomized clinical trials

Tailoring PCI: from full metal jacket to waistcoat

12 Feb 2024

A 38-year-old man with class III angina was referred for coronary angiography following a positive myocardial perfusion scan. The angiogram showed functionally occluded PDA as well as significant disease in the proximal, mid, and distal RCA. After wiring and predilating PDA, TIMI-III flow in PDA was...

Pr. Marcus Wiemer

Author

Marcus Wiemer
Dr. D.Pascut

Author

Dan Pascut
Tailoring PCI: from full metal jacket to a waistcoat

EuroIntervention: your academic reference journal for coronary, valvular and structural interventions

07 Feb 2024

EuroIntervention Journal is an international, English language, peer-reviewed journal which publishes high quality academic research in coronary, valvular, structural and surgical cardiovascular interventions.

EuroIntervention: Your reference journal for coronary, valvular and structural interventions

Five most impactful trials in 2023

02 Jan 2024 – From GulfPCR-GIM 2023

Find out how, based on an initial clinical situation, the scientific evidence gathered between January and December on the key subjects selected for 2023, focusing on coronary issues, might have had an impact on daily practice, or is encouraging changes in practice, from MVD in ACS...

Five most impactful trials in 2023

A stuck Rota burr in a "flintstone" coronary artery

18 Dec 2023

Step by Step video on how to deal with a stuck Rota burr with the same arterial access. Nice example of Kokeshi phenomenon.

Jorge Andres Chavarria Viquez

Author

Jorge Andres Chavarria Viquez
Adrián Lostalo

Author

Adrián Lostalo
A stuck Rota burr in a 'flintstone' coronary artery

Navigating complexity: surgical valve degeneration and complex coronary artery disease in a multimorbid patient

14 Dec 2023

How would you treat this 83-year-old male patient with LM, MVD, RCA CTO, severely reduced EF, and constrictive surgical valve?

Sadeek Sidney Kanoun Schnur

Author

Sadeek Sidney Kanoun Schnur

Author

Albrecht Schmidt
Dr. Gabor G. Toth

Author

Gabor G. Toth
Navigating complexity: surgical valve degeneration and complex CAD in a multimorbid patient

Dapagliflozin in acute myocardial infarction: Cardiometabolic benefits without impact on cardiovascular death or heart failure hospitalization: The jury is still out

14 Nov 2023

Luis Ortega Paz provides his take on DAPA-MI - A registry-based randomized trial of dapagliflozin in patient with acute myocardial infarction without diabetes, which was presented by Stefan James at AHA 2023 in Philadelphia.

Luis Ortega-Paz

Author

Luis Ortega-Paz
DAPA-MI - A registry-based randomized trial of dapagliflozin in patient with acute myocardial infarction without diabetes

Exploring advancements in drug-coated balloons (DCB)

22 Sep 2023 – From AICT-AsiaPCR 2023

Delve into the world of drug-coated balloons (DCB) with these presentations: from unexpected developments to unveiling the complications that often go unnoticed, learn why tortuosity matters in seemingly straightforward cases and explore the revolutionary procedure of metal-less PCI.

Exploring advancements in drug-coated balloons (DCB)

Advanced techniques for managing calcified lesions

22 Sep 2023 – From AICT-AsiaPCR 2023

Discover advanced strategies for tackling complex calcified lesions in this session: from innovative approaches like the 'Orbital-shock' technique to managing calcified lesions in patients with previous CABG and in-stent restenosis, and exploring calcium modification strategies tailored to specific cases, these presentations offer valuable insights into simplifying...

Advanced techniques for managing calcified lesions

Complex CTO challenges

22 Sep 2023 – From AICT-AsiaPCR 2023

Gain valuable insights into overcoming CTO challenges in this session: learn how IVUS can come to the rescue in cases of main branch cut-off, discover successful recanalization techniques for right coronary artery CTOs using very long epicardial channels and explore the best approaches for managing complex...

Complex CTO challenges